Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
gptkb:LBT-3627
gptkb:LBT-999 |
| gptkbp:focusesOn |
immunotherapy
peptide therapeutics |
| gptkbp:foundedYear |
2010
|
| gptkbp:founder |
gptkb:Scott_Shandler
|
| gptkbp:headquartersLocation |
gptkb:Philadelphia,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Longevity Biotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
synthetic peptide drugs
|
| gptkbp:targetMarket |
neurodegenerative diseases
age-related diseases autoimmune diseases |
| gptkbp:website |
https://www.longevitybiotech.com/
|
| gptkbp:bfsParent |
gptkb:Breakout_Labs
|
| gptkbp:bfsLayer |
6
|